Skip to main content
Erschienen in: Cancer Causes & Control 12/2011

01.12.2011 | Original paper

Occupational exposure to metal compounds and lung cancer. Results from a multi-center case–control study in Central/Eastern Europe and UK

verfasst von: Andrea ’t Mannetje, Vladimir Bencko, Paul Brennan, David Zaridze, Neonila Szeszenia-Dabrowska, Peter Rudnai, Jolanta Lissowska, Eleonóra Fabiánová, Adrian Cassidy, Dana Mates, Lenka Foretova, Vladimir Janout, Joelle Fevotte, Tony Fletcher, Paolo Boffetta

Erschienen in: Cancer Causes & Control | Ausgabe 12/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To study the association between occupational exposure to metals including chromium, cadmium, nickel, and arsenic compounds, within a population-based study design, while adjusting for confounding factors.

Methods

A population-based lung cancer case–control study in Central/Eastern Europe and UK was conducted in 1998–2003, including 2,853 cases and 3,104 controls. Exposure to 70 occupational agents was assessed by local expert-teams for all subjects. Odds ratios (OR) for exposure to dust and fumes/mist of chromium, nickel, cadmium, arsenic, as well as inorganic pigment dust and inorganic acid mist, were adjusting for smoking, age, center, sex, and exposure to other occupational agents including the metals under study.

Results

Exposure to arsenic (prevalence = 1.4%) was associated with an increased lung cancer risk ((OR) 1.65, 95% confidence interval (95% CI):1.05–2.58). For chromium dust (prevalence = 4.8%, OR: 1.25, 95% CI: 0.95–1.65), a linear upward trend for duration and cumulative exposure was observed. A weak association was observed for exposure to cadmium fumes (prevalence = 1.8%, OR: 1.19, 95% CI: 0.77–1.82), which was strongest for the highest category of cumulative exposure (OR: 2.04, 95% CI: 1.07–3.90). No increased risk was observed for inorganic acid mist, inorganic pigment dust, or nickel, after adjustment for other metals. An independent effect of nickel cannot be excluded, due to its collinearity with chromium exposure.

Conclusions

Occupational exposure to metals is an important risk factor for lung cancer. Although the strongest risk was observed for arsenic, exposure to chromium dust was most important in terms of attributable risk due to its high prevalence.
Literatur
1.
Zurück zum Zitat IARC (1980) Some metals and metallic compounds. International Agency for Research on Cancer, Lyon IARC (1980) Some metals and metallic compounds. International Agency for Research on Cancer, Lyon
2.
Zurück zum Zitat International Agency for Research on Cancer WHO (1987) Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1 to 42. IARC, Lyon International Agency for Research on Cancer WHO (1987) Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1 to 42. IARC, Lyon
3.
Zurück zum Zitat IARC (1990) Chromium, international agency for research on cancer. Nickel and Welding, Lyon IARC (1990) Chromium, international agency for research on cancer. Nickel and Welding, Lyon
4.
Zurück zum Zitat IARC (1993) Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. International Agency for Research on Cancer, Lyon IARC (1993) Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. International Agency for Research on Cancer, Lyon
5.
Zurück zum Zitat Mannetje A, Fevotte J, Fletcher T et al (2003) Assessing exposure misclassification by expert assessment in multicenter occupational studies. Epidemiology 14:585–592PubMedCrossRef Mannetje A, Fevotte J, Fletcher T et al (2003) Assessing exposure misclassification by expert assessment in multicenter occupational studies. Epidemiology 14:585–592PubMedCrossRef
6.
Zurück zum Zitat Fabianova E, Szeszenia-Dabrowska N, Kjaerheim K, Boffetta P (1999) Occupational cancer in central European countries. Environ Health Perspect Suppl 107:279–282 Fabianova E, Szeszenia-Dabrowska N, Kjaerheim K, Boffetta P (1999) Occupational cancer in central European countries. Environ Health Perspect Suppl 107:279–282
7.
Zurück zum Zitat Siemiatycki J, Wacholder S, Richardson L, Dewar R, Gerin M (1987) Discovering carcinogens in the occupational environment. Methods of data collection and analysis of a large case-referent monitoring system. Scan J Work Environ Health 13:486–492 Siemiatycki J, Wacholder S, Richardson L, Dewar R, Gerin M (1987) Discovering carcinogens in the occupational environment. Methods of data collection and analysis of a large case-referent monitoring system. Scan J Work Environ Health 13:486–492
8.
Zurück zum Zitat Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D (2010) GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer. 2010. Available from: http://globocan.iarc.fr Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D (2010) GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer. 2010. Available from: http://​globocan.​iarc.​fr
9.
Zurück zum Zitat Cassidy A, t Mannetje A, van Tongeren M et al (2007) Occupational exposure to crystalline silica and risk of lung cancer: a multicenter case-control study in Europe. Epidemiology 18:36–43PubMedCrossRef Cassidy A, t Mannetje A, van Tongeren M et al (2007) Occupational exposure to crystalline silica and risk of lung cancer: a multicenter case-control study in Europe. Epidemiology 18:36–43PubMedCrossRef
10.
Zurück zum Zitat Carel R, Olsson AC, Zaridze D et al (2007) Occupational exposure to asbestos and man-made vitreous fibres and risk of lung cancer: a multicentre case-control study in Europe. Occup Environ Med 64:502–508PubMedCrossRef Carel R, Olsson AC, Zaridze D et al (2007) Occupational exposure to asbestos and man-made vitreous fibres and risk of lung cancer: a multicentre case-control study in Europe. Occup Environ Med 64:502–508PubMedCrossRef
11.
Zurück zum Zitat Olsson AC, Fevotte J, Fletcher T et al (2010) Occupational exposure to polycyclic aromatic hydrocarbons and lung cancer risk: a multicenter study in Europe. Occup Environ Med 67:98–103PubMedCrossRef Olsson AC, Fevotte J, Fletcher T et al (2010) Occupational exposure to polycyclic aromatic hydrocarbons and lung cancer risk: a multicenter study in Europe. Occup Environ Med 67:98–103PubMedCrossRef
12.
Zurück zum Zitat Scelo G, Constantinescu V, Csiki I et al (2004) Occupational exposure to vinyl chloride, acrylonitrile and styrene and lung cancer risk (Europe). Cancer Causes Control 15:445–452PubMedCrossRef Scelo G, Constantinescu V, Csiki I et al (2004) Occupational exposure to vinyl chloride, acrylonitrile and styrene and lung cancer risk (Europe). Cancer Causes Control 15:445–452PubMedCrossRef
13.
Zurück zum Zitat Blair A, Stewart PA (1992) Do quantitative exposure assessments improve risk estimates in occupational studies of cancer? Am J Ind Med 21:53–63PubMedCrossRef Blair A, Stewart PA (1992) Do quantitative exposure assessments improve risk estimates in occupational studies of cancer? Am J Ind Med 21:53–63PubMedCrossRef
14.
Zurück zum Zitat Dewar R, Siemiatycki J, Gerin M (1991) Loss of statistical power associated with the use of a job-exposure matrix in occupational case-control studies. Appl Occup Environ Hyg 6:508–515CrossRef Dewar R, Siemiatycki J, Gerin M (1991) Loss of statistical power associated with the use of a job-exposure matrix in occupational case-control studies. Appl Occup Environ Hyg 6:508–515CrossRef
15.
Zurück zum Zitat Langard S (1993) Role of chemical species and exposure characteristics in cancer among persons occupationally exposed to chromium compounds. Scan J Work Environ Health 19(Suppl 1):81–89 Langard S (1993) Role of chemical species and exposure characteristics in cancer among persons occupationally exposed to chromium compounds. Scan J Work Environ Health 19(Suppl 1):81–89
16.
Zurück zum Zitat Gibb HJ, Lees PSJ, Pinsky PF, Rooney BC (2000) Lung cancer among workers in chromium chemical production. Am J Ind Med 38:115–126PubMedCrossRef Gibb HJ, Lees PSJ, Pinsky PF, Rooney BC (2000) Lung cancer among workers in chromium chemical production. Am J Ind Med 38:115–126PubMedCrossRef
17.
18.
Zurück zum Zitat Gerin M, Siemiatycki J, Richardson L, Pellerin J, Lakhani R, Dewar R (1984) Nickel and cancer associations from a multicancer occupation exposure case-referent study: preliminary findings, 53 edn. pp 105–115 Gerin M, Siemiatycki J, Richardson L, Pellerin J, Lakhani R, Dewar R (1984) Nickel and cancer associations from a multicancer occupation exposure case-referent study: preliminary findings, 53 edn. pp 105–115
19.
Zurück zum Zitat Beveridge R, Pintos J, Parent ME, Asselin J, Siemiatycki J (2010) Lung cancer risk associated with occupational exposure to nickel, chromium VI, and cadmium in two population-based case-control studies in Montreal. Am J Ind Med 53:476–485PubMed Beveridge R, Pintos J, Parent ME, Asselin J, Siemiatycki J (2010) Lung cancer risk associated with occupational exposure to nickel, chromium VI, and cadmium in two population-based case-control studies in Montreal. Am J Ind Med 53:476–485PubMed
20.
Zurück zum Zitat Shen HM, Zhan QF (1994) Risk assessment of nickel carcinogenicity and occupational lung cancer. Environ Health Perspect Suppl 102:275–282CrossRef Shen HM, Zhan QF (1994) Risk assessment of nickel carcinogenicity and occupational lung cancer. Environ Health Perspect Suppl 102:275–282CrossRef
21.
Zurück zum Zitat Sorahan T, Burges DC, Waterhouse JA (1987) A mortality study of nickel/chromium platers. Br J Ind Med 44:250–258PubMed Sorahan T, Burges DC, Waterhouse JA (1987) A mortality study of nickel/chromium platers. Br J Ind Med 44:250–258PubMed
22.
Zurück zum Zitat Sorahan T (1987) Mortality from lung cancer among a cohort of nickel cadmium battery workers: 1946–84. Br J Ind Med 44:803–809PubMed Sorahan T (1987) Mortality from lung cancer among a cohort of nickel cadmium battery workers: 1946–84. Br J Ind Med 44:803–809PubMed
23.
Zurück zum Zitat Sorahan T, Burges DC, L Hamilton, Harrington JM (1998) Lung cancer mortality in nickel/chromium platers, 1946–95. Occup Environ Med 55:236–242PubMedCrossRef Sorahan T, Burges DC, L Hamilton, Harrington JM (1998) Lung cancer mortality in nickel/chromium platers, 1946–95. Occup Environ Med 55:236–242PubMedCrossRef
24.
Zurück zum Zitat ICNC (1990) Report of the international committee on nickel carcinogenesis in man. Scan J Work Environ Health 16:1–82 ICNC (1990) Report of the international committee on nickel carcinogenesis in man. Scan J Work Environ Health 16:1–82
25.
26.
Zurück zum Zitat Stayner L, Smith R, Thun M, Schnorr T, Lemen R (1992) A dose-response analysis and quantitative assessment of lung cancer risk and occupational cadmium exposure. Ann Epidemiol 2:177–194PubMedCrossRef Stayner L, Smith R, Thun M, Schnorr T, Lemen R (1992) A dose-response analysis and quantitative assessment of lung cancer risk and occupational cadmium exposure. Ann Epidemiol 2:177–194PubMedCrossRef
27.
Zurück zum Zitat Kazantzis G, Lam TH, Sullivan KR (1988) Mortality of cadmium-exposed workers. A five-year update. Scan J Work Environ Health 14:220–223 Kazantzis G, Lam TH, Sullivan KR (1988) Mortality of cadmium-exposed workers. A five-year update. Scan J Work Environ Health 14:220–223
28.
Zurück zum Zitat Siemiatycki J (ed) (1991) Risk factors for cancer in the workplace. CRC Press, Boca Raton Siemiatycki J (ed) (1991) Risk factors for cancer in the workplace. CRC Press, Boca Raton
29.
Zurück zum Zitat Thun MJ, Elinder CG, Friberg L (1991) The scientific basis for an occupational standard for cadmium. Am J Ind Med 20:629–642PubMedCrossRef Thun MJ, Elinder CG, Friberg L (1991) The scientific basis for an occupational standard for cadmium. Am J Ind Med 20:629–642PubMedCrossRef
30.
Zurück zum Zitat Hu SW, Hertz-Picciotto I, Siemiatycki J (1999) When to be skeptical of negative studies: pitfalls in evaluating occupational risks using population-based case-control studies. Can J Public Health 90:138–142PubMed Hu SW, Hertz-Picciotto I, Siemiatycki J (1999) When to be skeptical of negative studies: pitfalls in evaluating occupational risks using population-based case-control studies. Can J Public Health 90:138–142PubMed
31.
Zurück zum Zitat IARC (1992) Occupational exposures to mists and vapours from strong inorganic acids and other industrial chemicals. International Agency for Research on Cancer, Lyon IARC (1992) Occupational exposures to mists and vapours from strong inorganic acids and other industrial chemicals. International Agency for Research on Cancer, Lyon
Metadaten
Titel
Occupational exposure to metal compounds and lung cancer. Results from a multi-center case–control study in Central/Eastern Europe and UK
verfasst von
Andrea ’t Mannetje
Vladimir Bencko
Paul Brennan
David Zaridze
Neonila Szeszenia-Dabrowska
Peter Rudnai
Jolanta Lissowska
Eleonóra Fabiánová
Adrian Cassidy
Dana Mates
Lenka Foretova
Vladimir Janout
Joelle Fevotte
Tony Fletcher
Paolo Boffetta
Publikationsdatum
01.12.2011
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 12/2011
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-011-9843-3

Weitere Artikel der Ausgabe 12/2011

Cancer Causes & Control 12/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.